Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained Authors: Erika Hamilton, MD; Nadia Harbeck, MD, PhD

https://www.medscape.org/viewarticle/1002403_sidebar12?sso=true&uac=148436CN&ecd=mkm_ret_251026_mscpmrk-ES_CME_etid7795962&impID=7795962